|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current assets | |||||||||
| Cash | |||||||||
| Short-term prepaid insurance | |||||||||
| Prepaid expenses | |||||||||
| Total current assets | |||||||||
| Deferred offering costs | |||||||||
| Long-term prepaid insurance | |||||||||
| Investments held in Trust Account | |||||||||
| Total Assets | |||||||||
| Liabilities and Shareholders' Deficit | |||||||||
| Current liabilities | |||||||||
| Accrued expenses | |||||||||
| Advances from related party | |||||||||
| Accrued offering costs | |||||||||
| Promissory note - related party | |||||||||
| Total current liabilities | |||||||||
| Deferred legal fees | |||||||||
| Deferred underwriting fee | |||||||||
| Total Liabilities | |||||||||
| Class A ordinary shares subject to possible redemption; 20,000,000 shares at redemption value of $10.86 and $10.67 per share as of June 30, 2026 and December 31, 2025, respectively | |||||||||
| Class A common stock subject to possible redemption | |||||||||
| Total class A ordinary shares subject to possible redemption; 20,000,000 shares at redemption value of $10.86 and $10.67 per share as of June 30, 2026 and December 31, 2025, respectively | |||||||||
| Shareholders' Deficit | |||||||||
| Ordinary shares | |||||||||
| Class A ordinary shares | |||||||||
| Class B ordinary shares | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated deficit | |||||||||
| Total Shareholders' Deficit | |||||||||
| Total Liabilities and Shareholders' Deficit |
Loading...
